Skip to main content
. Author manuscript; available in PMC: 2015 May 14.
Published in final edited form as: Cancer Gene Ther. 2014 Nov 14;21(11):483–490. doi: 10.1038/cgt.2014.54

Figure 6.

Figure 6

Flank tumor growth was suppressed by intratumoral MV-NIS therapy. OS flank xenografts were treated every four days with intratumoral injections of 1×106 TCID50 MV-GFP, MV-NIS, or heat-inactivated control virus (n=5 per group), which led to suppression of tumor growth both in MV-GFP (p=0.0407) and MV-NIS (p=0.0374) treated mice.